|
Current Molecular Pharmacology
ISSN: 1874-4672 - Volume 1, 3 Issues 2008
Instructions for Authors
Manuscripts should be submitted openly to the following Editor-in-Chief
without prior invitation at the following address: Dr.
Nouri Neamati, Editor-in-Chief,
Current Molecular Pharmacology, Department of
Pharmacology and Pharmaceutical Sciences, School of Pharmacy,
University of Southern California, 1985 Zonal Avenue, Room
304, Los Angeles, CA 90089, USA, Phone: +1 323-442-2341, Fax:
+1 323-442-1390, Email: neamati@usc.edu
Manuscript Preparation: The journal publishes
both mini-review and full-length review articles. For full
length review articles, the manuscript, written in English,
should not exceed 70 pages in length (ca. 30 printed pages)
and for mini-reviews a maximum of 40 manuscript pages in length
(ca. 15 printed pages). The manuscript should be typed in
double spacing throughout on A-4 or American quarto paper.
Dot matrix print or any print that is difficult to read is
unacceptable. All pages should be numbered. Abbreviations
should be defined the first time that they are used in the
manuscript and a list of abbreviations used should also be
provided.
Manuscript Organization: TThe manuscript
should be divided as: Title page, abstract and the main text.
The text may further be subdivided according to the areas
to be discussed. This should be followed by the Acknowledgment
(if any) and Reference sections. The first page should contain
the title, the authors, names (initials and surname only),
with an asterisk at the end of the name of the principal author.
Conflict of Interest: Financial contributions
to the work being reported should be clearly acknowledged,
as should any potential conflict of interest.
Abstract: The abstract should not exceed
250 words and it should condense the essential features of
the article.
Key Words: Authors must supply up to eight
key words along with their manuscript.
Text: The main text should begin on a separate
page and it may be subdivided into separate sections. The
reference numbers should be given in square brackets in the
text. Acknowledgements should be kept to a minimum.
Tables:
- Data Tables should
be submitted in Microsoft Excel or in Microsoft Word table
format.
- Each table should include
a title/caption explaining what the table shows. Detailed
legends may then follow.
- Tables should be given
on separate pages with indications on the left hand margin
to the text, as to the appropriate placement of the tables.
- Tables should not contain
vertical rules.
- Columns and rows of
data should be made visibly distinct by ensuring the borders
of each cell display as black lines.
- Tables should be numbered
consecutively in order of their citation in the body of
the text, with Arabic numerals.
- If a reference is cited
in both the table and text, insert a lettered footnote in
the table to refer to the numbered reference in the text.
Figures / illustrations:
All authors must strictly follow the guidelines below for
preparing illustrations for publication in Current
Molecular Pharmacology.
Editorial Requirements:
The quality of the illustrations printed in the journal
largely depends on the quality of the figures/illustration provided by the author.
In preparing artwork or graphics for publication, keep in mind the following points.
- Submit the original artwork or a photographic
print of the original for publication.
- Do not submit photocopies.
- The illustrations should be provided as separate
files and not embedded in the text.
- Remove all color from graphics except for
those illustrations (Greyscale), which are intended to be
printed in color.
- Figures should be referred to as “Fig.
(1)”, “Fig. (2)”
etc. in the text with figure numbers in bold within round
bracket.
- Revised manuscripts should contain a complete
set of artwork and photographs.
Format & Resolution:
- The following file formats can be accepted.
(Preference in order of appearance): PDF, TIFF, JPEG, GIF.
- Illustrations
must fit a single or double column format on the journal page, according to the
following guideline below:
|
HEIGHT | WIDTH |
SINGLE COLUMN |
24 cm (max) |
8.5 cm (max) | DOUBLE
COLUMN | 24
cm (max) | 18
cm (max) |
- Whenever possible, submit graphics that do
not have to be reduced to fit the standard figure size.
- Use the best resolution available. For online
submission the maximum resolution is 300 dpi.
- Avoid textures and shadings giving a three-dimensional
effect to the illustration.
- Symbols and lettering in the illustration
should be of similar size.
- Smaller lettering is used.
- Font: Times New Roman or Helvetica is preferable.
Font size: 10pt (maximum).
- Line drawings should have clear and sharp
lines and should be of uniform density. Moreover, lines
should be continuous without any breaks.
- Do not use lines thinner than 1 point.
Color Figures / Illustrations:
Chemical Structures: : Chemical structures must be
prepared according to the guidelines below.
Structures should be prepared using a suitable drawing program
e.g. ChemDraw and provided as separate file.
Numbers in bold should identify all chemical structure. If
a name is also used to describe the compound, the associated
number if required, should be in bold and parenthesis, e.g.
“compound (1)”.
Structure Drawing Preferences:
[As according to the ACS style sheet]
Drawing Settings:
Chain angle 120º
Bond spacing 18% of width Fixed length 14.4
pt (0.500cm, 0.2in) Bold width
2.0 pt (0.071cm, 0.0278in) Line width
0.6 pt (0.021cm, 0.0084in) Margin width
1.6 pt (0.096cm) Harsh spacing 2.5 pt (0.088cm, 0.0347in)
Text settings:
Font Times
New Roman / Helvetica Size 10pt
Under the Preference Choose:
Units
points Tolerances 3
pixels
Under Page Setup Use:
Paper US
letter Scale
100%
References: All references must
be numbered in the text in square brackets, e.g. [4], or [7-10,
15], in the order of citation in the text. Example:
[1] Seymore, L. Novel Anti-Cancer Agents in Development: Exciting
Prospects and New Challenges. Cancer Treat. Revs.
1999, 25, 301-312.
[2] Furfine, E. S.; Leban, J. J.; Landavazo, A.; Moomaw, J.
F.; Casey, P. J. Protein Farnesyltransferase: Kinetics of
Farnesyl Pyrophosphate Binding and Product Release. Biochemistry
1995, 34, 6857-6862.
[3] Boyd, M. R. In Anticancer Drug Development Guide:
Preclinical Screening, Clinical Trials, and Approval;
Teicher, B. A., Ed.; Humana Press: Totowa, NJ, 1997,
pp. 23-42.
[4] Boynton, A. L.; McKeehan, W. L.; Whitfield, J. F., Eds.
Ions, Cell Proliferation and Cancer; Academic Press:
New York, 1982.
Abstracts, unpublished data and personal communications (which
can be only included if permission has been obtained) should
not be given in the reference section but they may be mentioned
in the text and details provided as footnotes. All authors
of referenced papers must be cited and there must be no use
of the short hand version of et al. when citing the authors.
Manuscript Submission: To achieve rapid publication
authors are encouraged to e-mail their submission to the appropriate
editorial office (see above). For even faster publication,
authors are encouraged to submit their entire manuscript via
Bentham’s online submission service (see below). Authors
must provide their full address, telephone and Fax numbers
with E-Mail address with all submissions.
Online Manuscript Submission: (preferable)
To facilitate speedy and cost-effective submission of abstracts
and manuscripts, an online submission and tracking service
via Internet is being offered. Once the Editor-in-Chief of
the journal has accepted your abstract, we would prefer that
you submit your full manuscript online via our online submission
service available at http://www.bentham-mps.org
or by FTP submission at www.bentham-ftp.org
A successful electronic submission of a manuscript will be
followed by a system-generated acknowledgement to the principal/corresponding
author within 72 hours of the dispatch of the manuscript.
Any queries therein should be addressed to mahmood@bentham.org
and copied to Jalil@bentham.org
For online submission, please provide your complete manuscript
in the form of a single zipped folder containing
all the material (main text, figures/ illustrations, scanned
photographs, tables, chemical structures drawn in ChemDraw)
as separate files and a PDF version
of the entire manuscript with all the figures/ illustrations
/ tables / chemical structures etc., embedded in the text
exactly in the manner as they should appear in printing.
Authors are required to proofread the PDF version of their
manuscript before submission. The article will be published
exactly as received and the Publishers will not be responsible
for any error occurring in the manuscript in this regard.
Page Charges: No page charges will be levied to authors.
Language Editing: Manuscripts submitted containing
many English typographical errors will not be published. Authors
from non-English language countries are advised to use the
services of our professional language editing department prior
to submitting their manuscript to the Journal. Please contact
Bentham Publishing Services www.benthampublishingservices.com
for a language editing quote at e-mail: info@benthampublishingservices.com
stating the total number of words of the article to be edited.
Proofs: Authors are sent page proofs. To
avoid delays in publication, proofs should be checked immediately
for typographical errors and returned within 48 hours. Authors
will be charged for excessive changes made at the page proof
stage.
Reprints: Each first named author will receive
by e-mail a free copy of their article as a PDF file. The
PDF file is a watermarked version of the published article
which is exclusively for the author's own use and may not
be copied or distributed. Reprints may be ordered from the
Publisher prior to publication of the article. First named
authors may also order a personal print and online subscription
of the journal at 50% off the normal subscription rate by
contacting the subscription department at e-mail: subscriptions@bentham.org
Bentham Open Access: Accepted articles can
be published online for free open access for all to view.
Open access publishing provides the maximum dissemination
of the article to the largest audience. Authors must pay for
this service. All corresponding authors will be asked to indicate
whether or not they wish to pay to have their paper made freely
available on publication. If authors do not select the Open
Access option, then their article will be published with standard
subscription-based access at no charge. Open access articles
are published under the terms of the Creative Commons Attribution
Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)
which permits unrestricted, non-commercial use, distribution
and reproduction in any medium, provide the work is properly
cited.
Bentham Science offers authors the choice of open access publication
of their articles at a fee of US$ 1,500
per published article which allows indefinite online
publication with BOTH Bentham Science and PubMed Central.
Alternatively, authors may choose to publish their article
with Bentham Science at a reduced fee for a limited open access
period. Bentham Science is the first and only publisher to
offer authors the choice at a reduced open access fee to have
their article published for a limited open access period.
For open access publication for a period of twelve months
(limited open access) the per article fee is US$
750 . For more information please contact us at e-mail:
openaccess@bentham.org
Reviewing and Promptness of Publication:
All papers submitted for publication will be immediately subjected
to editorial scrutiny, usually in consultation with members
of the Editorial Advisory Board. Every effort will be made
to assess the papers quickly. The papers will be typeset and
the proofs dispatched to the authors normally within 4 weeks
of their acceptance.
Copyright: It is a condition of publication
that manuscripts submitted to this journal have not been published
and will not be simultaneously submitted or published elsewhere.
Plagiarism is strictly forbidden, and by submitting the article
for publication the authors agree that the publishers have
the legal right to take appropriate action against the authors,
if plagiarism is discovered. By submitting a manuscript the
authors agree that the copyright of their article is transferred
to the publishers if and when the article is accepted for
publication.
|
